A Study of iPS Cell-derived Cardiomyocyte Spheroids (HS-001) in Patients With Heart Failure (LAPiS Study)
Phase 1
Active, not recruiting
- Conditions
- Ischemic Heart DiseaseHeart Failure
- Interventions
- Biological: HS-001 CSDevice: HS-001-D needle, HS-001-D Adaptor
- First Posted Date
- 2021-06-30
- Last Posted Date
- 2025-03-13
- Lead Sponsor
- Heartseed Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT04945018
- Locations
- π―π΅
Nihon University Itabashi Hospital, Tokyo, Japan
π―π΅St. Marianna University Hospital, Kawasaki, Japan
π―π΅Saitama Medical University International Medical Center, Saitama, Japan
Β© Copyright 2025. All Rights Reserved by MedPath